首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1739592

藥房自動化市場按產品、藥房類型、藥房規模、應用、最終用戶、分銷管道和地區分類（2026 年至 2032 年）

Pharmacy Automation Market By Product, Pharmacy Type, Pharmacy Size, Application, End-User, Distribution Channel, & Region for 2026-2032

出版日期: 2025年05月12日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

藥房自動化市場評估（2026-2032）

用藥錯誤發生率的上升可能導致嚴重的健康後果，這是推動藥局自動化發展的關鍵因素。預計到2024年，藥局自動化市場規模將達到56.2億美元，到2032年將達到95.9億美元。

由於全球人口老化和慢性病增加導致處方藥需求激增，預計 2026 年至 2032 年市場複合年成長率將達到 7.62%，這給藥房等醫療機構在管理庫存、配藥和確保及時送達患者方面帶來了挑戰。

藥房自動化市場定義/概述

藥局自動化是指利用科技簡化和自動化藥局內藥品處理、儲存、調配和管理的各種流程。它結合了機器、機器人和軟體系統，旨在執行先前由藥劑師和技術人員手動執行的重複性任務。

藥房自動化的主要目標是提高業務效率、提升準確性、減少用藥錯誤，並最終提供更優質的患者照護。透過實現錠劑計數、庫存管理和處方箋標籤等任務的自動化，藥房可以顯著降低人為錯誤的風險，同時讓員工專注於更複雜、以患者為中心的工作。自1960年代末期簡單的錠劑計數機問世以來，藥房自動化已發展成為整合人工智慧和機器學習等先進技術的複雜系統，徹底改變了當今藥房的運作方式。

減少用藥錯誤的日益成長的需求將如何推動藥房自動化市場的發展？

減少用藥錯誤的需求日益成長，這是藥房自動化市場的主要驅動力，因為用藥錯誤會嚴重威脅病患安全。根據美國食品藥物管理局(FDA) 的數據，光是在美國，每年就有約 150 萬人因用藥錯誤而受害。世界衛生組織 (WHO) 也估計，此類錯誤每年在全球整體導致 12.5 萬例可預防死亡。這些令人擔憂的統計數據凸顯了對自動化系統的迫切需求，該系統能夠提高配藥和用藥的準確性，並減少人為錯誤的可能性。

自動配藥櫃和機器人系統等藥房自動化技術簡化了各種藥房業務，並顯著降低了與手動流程相關的錯誤風險。根據美國安全用藥實踐研究所 (ISM) 的一項研究，大約 40% 的用藥錯誤發生在續藥作業期間，並且經常被忽視，直到導致不利事件發生。透過實施自動化解決方案，藥局可以提高病患安全性和業務效率，同時減輕醫護人員管理複雜用藥方案的負擔。隨著醫療服務提供者尋求提高護理品質並最大限度地降低相關風險，對減少錯誤的關注正在推動藥房自動化的發展。

高昂的初始資本成本將如何影響藥局自動化技術的採用？

高昂的前期投資成本對藥局自動化技術的採用有重大影響，也是許多醫療保健機構面臨的一大障礙。實施這些系統通常需要大量資金用於設備購買、基礎設施改造以及與現有工作流程的整合。一份報告顯示，約80%的初級保健機構認為缺乏資金支持是實施自動化系統的主要障礙。

此外，美國食品藥物管理局(FDA) 強調，由於用藥錯誤會導致醫療成本增加，需要經濟高效的解決方案。因此，儘管自動化的長期效益可能顯著，但初期成本阻礙了許多藥局的轉型，減緩了整體市場的成長。

McKesson Corporation
Omnicell, Inc.
Cerner Corporation
Swisslog Holding AG
BD（Becton, Dickinson and Company）
Capsa Healthcare
Parata Systems LLC
ScriptPro LLC
ARxIUM Inc.
TCGRx
Talyst
Baxter International
Health Robotics SRL
Yuyama , Ltd.
Pearson Medical Technologies
Kirby Lester
Willach Pharmacy Solutions
Innovation Associates
KUKA AG

第14章市場展望與機會

新興技術
未來市場趨勢
投資機會

第15章附錄

簡稱列表
來源和參考文獻

簡介目錄

Product Code: 59412

Pharmacy Automation Market Valuation - 2026-2032

The rising incidence of medication errors, which can lead to severe health consequences, is a significant driver for pharmacy automation. The pharmacy automation market size is estimated at USD 5.62 Billion in 2024, and is expected to reach USD 9.59 Billion by 2032.

The aging global population and rising chronic diseases have led to a surge in prescription medication demand, posing challenges for healthcare facilities like pharmacies in managing inventory, dispensing medications, and ensuring timely patient delivery enabling the market grow at a CAGR of 7.62% from 2026 to 2032.

Pharmacy Automation Market: Definition/ Overview

Pharmacy automation refers to the use of technology to streamline and automate various processes involved in the handling, storage, dispensing, and management of medications within a pharmacy. This includes a combination of machines, robotics, and software systems designed to perform repetitive tasks that would otherwise be done manually by pharmacists and technicians.

The primary goal of pharmacy automation is to enhance operational efficiency, improve accuracy, reduce medication errors, and ultimately provide better patient care. By automating tasks such as counting pills, managing inventory, and labeling prescriptions, pharmacies can significantly decrease the risk of human error while also freeing up staff to focus on more complex and patient-centered activities. Since its inception in the late 1960s with simple pill- counting machines, pharmacy automation has evolved into sophisticated systems that integrate advanced technologies like artificial intelligence and machine learning, transforming how pharmacies operate today.

What Role does the Increasing Need to Minimize Medication Errors Play in Driving the Pharmacy Automation Market?

The increasing need to minimize medication errors significantly drives the pharmacy automation market, as these errors pose serious risks to patient safety. According to the U.S. Food and Drug Administration (FDA), medication errors harm approximately 1.5 million people annually in the United States alone. Additionally, the World Health Organization (WHO) estimates that these errors lead to 125,000 preventable deaths each year globally. Such alarming statistics underscore the urgent need for automated systems that enhance accuracy in medication dispensing and management, thereby reducing the likelihood of human error.

Pharmacy automation technologies, such as automated dispensing cabinets and robotic systems, streamline various pharmacy operations, significantly decreasing the risk of mistakes associated with manual processes. A study by the Institute for Safe Medication Practices found that about 40% of medication errors occur during the refill process, often going unnoticed until they result in adverse events. By implementing automation solutions, pharmacies can improve patient safety and operational efficiency while alleviating the burden on healthcare professionals managing complex medication regimens. This focus on error reduction is propelling the growth of pharmacy automation as healthcare providers seek to enhance care quality and minimize associated risks.

How do High Initial Investment Costs Impact the Adoption of Pharmacy Automation Technologies?

High initial investment costs significantly impact the adoption of pharmacy automation technologies, posing a considerable barrier for many healthcare providers. Implementing these systems often requires substantial financial outlay for equipment, infrastructure modifications, and integration with existing workflows. According to a report, around 80% of primary care setups cite a lack of financial support as a major hindrance to adopting automation systems.

Additionally, the U.S. Food and Drug Administration (FDA) has highlighted that medication errors lead to increased healthcare costs, emphasizing the need for cost-effective solutions. Consequently, while the long-term benefits of automation may be substantial, the upfront costs deter many pharmacies from making the transition, slowing overall market growth.

Category-Wise Acumens

How do Inpatient Pharmacy Automation Systems Enhance the Tracking and Management of Controlled Substances?

Inpatient pharmacy automation systems enhance the tracking and management of controlled substances by providing real-time visibility and accountability throughout the medication-use process. For instance, a study at Houston Methodist Hospital demonstrated that implementing mobile medication tracking technology improved documentation accuracy significantly, with missing documents dropping from 29 to zero after transitioning from a paper-based system.

This technology ensured that 140 out of 141 medications had receiving personnel information documented electronically, improving the capture rate of medication delivery personnel from 67.4% to 92.9%. Such advancements minimize the risk of diversion and enhance compliance with regulations set by the U.S. Drug Enforcement Administration (DEA).

Additionally, automated systems streamline the ordering, storing, and dispensing processes for controlled substances, which helps reduce human error and improve overall efficiency. The FDA emphasizes the importance of meticulous record-keeping for controlled substances to prevent misuse, and automated systems facilitate this by providing accurate tracking and reporting capabilities. By integrating these technologies into hospital workflows, pharmacies can ensure a reliable chain of custody for controlled substances, thereby enhancing patient safety and supporting healthcare providers in maintaining compliance with regulatory requirements.

What Role does Regulatory Compliance Play in Motivating Large Size Pharmacies to Adopt Pharmacy Automation Technologies?

Regulatory compliance plays a crucial role in motivating large size pharmacies to adopt pharmacy automation technologies. With stringent regulations set by agencies such as the U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS), large pharmacies must ensure they meet various safety and quality standards. For instance, the FDA emphasizes the importance of accurate record-keeping and reporting, which can be labor-intensive and prone to human error when done manually. Automation systems streamline data collection and reporting processes, significantly reducing the risk of compliance issues.

Moreover, automated systems can monitor access to protected health information (PHI) and alert staff to potential compliance violations, thereby enhancing accountability. The Health Insurance Portability and Accountability Act (HIPAA) mandates strict data privacy measures, and automation aids in maintaining these standards by ensuring secure handling of sensitive information. By leveraging automation technologies, large pharmacies can improve their compliance efforts, reduce the likelihood of costly penalties, and enhance overall operational efficiency, making them more agile in responding to regulatory changes.

Country/Region-wise Acumens

What Factors Contribute to the Rapid Growth of Pharmacy Automation Technologies in the Asia Pacific Region?

The rapid growth of pharmacy automation technologies in the Asia Pacific region is driven by several key factors. A significant contributor is the aging population, with projections indicating that by 2025, Asia will have 456 million seniors aged 65 or older, representing 10% of its population. This demographic shift increases the demand for efficient medication management systems.

Additionally, government initiatives aimed at improving healthcare access and quality are crucial; for instance, the Asian Development Bank (ADB) has committed over USD 20 Billion in assistance to enhance healthcare systems in response to challenges posed by the COVID-19 pandemic. These factors, combined with rising consumer expectations and technological advancements, create a conducive environment for the swift adoption of pharmacy automation technologies across the region.

What Technological Innovations are Driving the Adoption of Pharmacy Automation Systems in North America?

Technological innovations are pivotal in driving the adoption of pharmacy automation systems in North America. Key advancements include robotic dispensing systems, which enhance accuracy by automating the counting, labeling, and dispensing of medications. For instance, the U.S. Food and Drug Administration (FDA) reports that medication errors contribute to approximately 100,000 adverse events annually, highlighting the urgent need for solutions that minimize such risks.

Additionally, artificial intelligence (AI) and machine learning are being integrated into inventory management systems to optimize stock levels and reduce waste. The Centers for Medicare & Medicaid Services (CMS) also supports the use of automation to improve patient safety and operational efficiency. As healthcare providers increasingly focus on minimizing medication errors and enhancing workflow, these technological innovations are essential in transforming pharmacy operations, ultimately leading to better patient outcomes and satisfaction.

Competitive Landscape

The competitive landscape of the pharmacy automation market is characterized by intense competition among a diverse array of players, including established pharmaceutical companies, medical device manufacturers, and technology firms.

Some of the prominent players operating in the pharmacy automation market include:

McKesson Corporation
Omnicell,
BD (Becton, Dickinson and Company)
AmerisourceBergen Corporation
Swisslog Healthcare
Capsa Healthcare
Talyst,
Cerner Corporation
Baxter International
ScriptPro LLC
ARxIUM,
Health Robotics SRL
Yuyama , Ltd.
ScriptPro LLC
TCGRx
Pearson Medical Technologies
Kirby Lester
Willach Pharmacy Solutions
Innovation Associates
KUKA AG

Latest Developments

In April 2024, Omnicell Launch XR2 Automated Central Pharmacy System, which offers a fully automated approach to medication inventory management, enhancing patient safety through 100% barcode scanning and reducing expired medication
In January 2024, AmerisourceBergen completed its acquisition of PharmaLex Holding GmbH, enhancing its specialty services and expanding its platform for pharmaceutical manufacturer services, which includes pharmacy automation